Literature DB >> 23661602

Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question?

Barbara Testoni1, Massimo Levrero, David Durantel.   

Abstract

Entities:  

Keywords:  CHRONIC VIRAL HEPATITIS; HEPATITIS C

Mesh：

Substances：

Year:  2013        PMID： 23661602     DOI： 10.1136/gutjnl-2013-304528

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  4 in total

1.  Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.

Authors:  Eric G Meissner; David Wu; Anu Osinusi; Dimitra Bon; Kimmo Virtaneva; Dan Sturdevant; Steve Porcella; Honghui Wang; Eva Herrmann; John McHutchison; Anthony F Suffredini; Michael Polis; Stephen Hewitt; Ludmila Prokunina-Olsson; Henry Masur; Anthony S Fauci; Shyamasundaran Kottilil
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

2.  Fuzzy logic and Lyapunov-based non-linear controllers for HCV infection.

Authors:  Ali Hamza; Iftikhar Ahmad; Muhammad Uneeb
Journal:  IET Syst Biol       Date:  2021-04       Impact factor: 1.615

3.  Achieving sustained virologic response after interferon-free hepatitis C virus treatment correlates with hepatic interferon gene expression changes independent of cirrhosis.

Authors:  E G Meissner; A Kohli; K Virtaneva; D Sturdevant; C Martens; S F Porcella; J G McHutchison; H Masur; S Kottilil
Journal:  J Viral Hepat       Date:  2016-02-03       Impact factor: 3.728

4.  Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.

Authors:  Ayesha Obaid; Anam Naz; Aqsa Ikram; Faryal Mehwish Awan; Abida Raza; Jamil Ahmad; Amjad Ali
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.